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Abstract
Background—Tricuspid regurgitation (TR) is a risk factor for mortality in pulmonary 
hypertension (PH). TR severity varies among patients with comparable degrees of PH and right 
ventricular (RV) remodeling. The contribution of leaflet adaptation to the pathophysiology of TR 
has yet to be examined. We hypothesized that tricuspid leaflet area (TLA) is increased in PH, and 
that its size relative to RV remodeling determines TR severity.
Methods and Results—A prospective cohort of 255 patients with PH from pre- and post-
capillary etiologies was assembled from two centers. Patients underwent a 3-D echocardiogram 
focused on the tricuspid apparatus. TLA was measured with the Omni custom software package. 
Compared with normal controls, PH patients had a twofold increase in RV volumes, 62% increase 
in annulus area, and 49% increase in TLA. Those with severe TR demonstrated inadequate 
increase in TLA relative to the closure area, such that the ratio of TLA-to-closure area <1.78 was 
highly predictive of severe TR (odds ratio 68.7; 95% CI 16.2, 292.7). The median vena contracta 
width was 8.5 mm in the group with small TLA and large closure area as opposed to 4.8 mm in 
the group with large TLA and large closure area.
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Conclusions—TLA plays a significant role in determining which patients with PH develop 
severe functional TR. The ratio of TLA-to-closure area, reflecting the balance between leaflet 
adaptation vs. annular dilation and tethering forces, is an indicator of TR severity that may identify 
which patients stand to benefit from leaflet augmentation during tricuspid valve repair.
Keywords
tricuspid regurgitation; pulmonary hypertension; echocardiography
Severe tricuspid regurgitation (TR) develops in 10-30% of patients with pulmonary 
hypertension (PH) and presages death in 1/3 such patients within one year1-3. Predicting and 
averting the development of severe TR is problematic since there is substantial variability in 
who develops severe TR, even after adjusting for pulmonary artery pressure and size of the 
tricuspid annulus and right ventricle (RV). This uncertainty has been attributed in part to an 
incomplete understanding of the pathophysiology at hand4.
Functional TR, which represents 90% of cases5, results from geometric distortions in any of 
four inter-related components: (1) tricuspid valve leaflets, (2) tricuspid annulus, (3) papillary 
muscles and chordae, and (4) right ventricular size and shape, including the interventricular 
septum and left ventricular interactions. To date, the emphasis has primarily been on 
tricuspid annulus dilation, and secondarily on right ventricular remodeling with papillary 
muscle displacement leading to tethering6.
The contribution of the tricuspid leaflets to the pathophysiology of functional TR has largely 
been neglected, perhaps owing to the concept that the leaflets should be “normal” in 
functional valvulopathies, or to inherent challenges in quantitatively measuring leaflet 
tissue. In prior work, our group developed and validated a technique to measure mitral 
leaflet area and demonstrated that ventricular dilation was accompanied by mitral leaflet 
growth so that mitral regurgitation developed when leaflet growth was inadequate to cover 
the valve closure area7.
By defining the 3-D changes in leaflet, annular, ventricular, and tethering geometry using 
our previously validated approach, the objective of this study was to determine whether 
tricuspid leaflet surface area (TLA) was correlated with functional TR in a cohort of patients 
with PH. We hypothesized that TLA is increased in in PH, and that its adequacy relative to 
RV remodeling is a strong determinant of TR severity.
This hypothesis, if correct, would provide the justification and context to investigate the 
mechanisms of leaflet adaptation8 and the use of leaflet augmentation as a therapeutic 
procedure for functional TR, which is currently a topic of ongoing debate9. Although not yet 
proven, patients with inadequate leaflet adaptation would be expected to benefit more from 
leaflet augmentation. Echocardiographic research10 has been instrumental in guiding therapy 
for TR, leading to: (i) a redesigned tricuspid annuloplasty ring that mimics the natural 3-
dimensional saddle-shape of the annulus (MC3, Edwards, Irvine, CA), (ii) guideline 
recommendations to repair functional TR if the annular dilation exceeds 40 mm11,12, and in 
some centers, (iii) an adopted practice to perform leaflet augmentation if the tenting distance 
exceeds 8 mm13,14.
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Methods
Study Design
A prospective two-center cohort of patients with PH was assembled. Patients underwent a 
standardized 2-D and 3-D echocardiographic assessment, with a specific focus on the right 
heart and tricuspid valve. The dependent variable was severity of TR quantified according to 
the vena contracta (VC) width15. TLA was measured offline using the Omni 4D custom 
software package. The independent variable of interest was the ratio of TLA divided by 
tricuspid closure area, which reflects the adaptation (i.e. growth) of the valve leaflets to 
cover the distended and tented systolic closure area and thus maintain valvular competency. 
Each center's institutional review committee approved the study and patients provided 
informed consent to be included.
Setting
Patients were identified and recruited from the pulmonary hypertension programs at the 
Massachusetts General Hospital (Boston, MA) and Hammersmith Hospital (London, UK), 
both of which are tertiary referral centers for patients with PH. Recruitment at the 
Massachusetts General Hospital occurred between May 2012 and March 2013. Recruitment 
at the Hammersmith Hospital occurred between January 2012 and April 2013. 
Echocardiograms were performed and analyzed in the cardiac ultrasound facilities of the 
respective hospitals, using the Philips IE33 machine and Xcelera/QLAB workstation 
(Philips Medical Systems, Andover, MA) at the former, and the GE Vivid 7 machine and 
EchoPAC workstation (GE, Milwaukee, WI) at the latter.
Participants
Inclusion criteria were: (1) TR velocity ≥3.5 meters/second, corresponding to an estimated 
pulmonary artery systolic pressure (PASP) of ≥50 mm Hg, (2) diagnosis of PH confirmed by 
a cardiologist or pulmonologist within the pulmonary hypertension program. The majority 
of patients had undergone diagnostic right heart catheterization as part of their initial clinical 
investigations. Invasive PASP was not re-measured for the purposes of this study, therefore 
noninvasive PASP was used to identify eligible patients, and those with insufficient TR jet 
signal to obtain a noninvasive PASP were excluded. Other exclusion criteria were: atrial 
fibrillation at the time of the echocardiogram, inadequate image quality to visualize the right 
heart and/or tricuspid valve, pacemaker, and organic TR etiology. All types of PH were 
eligible, including pre-capillary (pulmonary arterial hypertension, chronic thromboembolic 
PH) and post-capillary (PH due to left-heart diseases). In addition, measurements of TLA 
and closure area were obtained in a group of 34 normal controls free of structural heart 
disease who were referred to the echocardiography lab.
Echocardiographic Protocol
A comprehensive echocardiogram was performed, with special attention to optimize the 
right heart acquisitions. The RV was imaged from multiple views, including but not limited 
to the RV inflow view, RV-focused and RV-modified apical 4-chamber views. The TR jet 
was imaged by color Doppler in the parasternal RV inflow view, parasternal short axis view, 
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apical 4-chamber view, and subcostal view. In each of these views, the color Doppler 
baseline was lowered to 28 ± 8 cm/s to optimize the VC appearance. 2-D measures of RV 
size and function were made according to the American Society of Echocardiography 
guidelines for the echocardiographic assessment of the right heart16. All measurements were 
made at held end-expiration.
The 3-D echocardiographic protocol consisted of 4-beat full volume acquisitions in the RV-
focused apical 4-chamber view and the parasternal RV inflow view, and in a subset of 
patients, 6-beat full volume color Doppler acquisitions in the same two views. A single-beat 
3-D zoom was also obtained. The sector depth, sector width, and elevation width were 
adjusted to focus on the tricuspid valve leaflets throughout the cardiac cycle. For full volume 
color Doppler acquisitions, a minimum frame rate of 12 per second was required; the 
number of beats in the full volume acquisition could be increased to obtain a higher frame 
rate if the R-R intervals were regular. QLAB's multi-plane reconstruction (Philips Medical 
Systems, Andover, MA) was used to measure VC area, and TomTec's 4-D RV Function 
(TomTec, Munich, Germany) was used to measure RV volumes.
Measurement of TR Severity
The VC width was measured in duplicate or triplicate (i.e. in 2-3 successive beats) with held 
end-expiration from the apical 4-chamber and parasternal RV inflow views. To account for 
the possibility of nonsymmetrical orifices, biplane VC width was calculated by averaging 
the VC widths from these two roughly orthogonal views. This biplane VC approach has 
been validated in mitral regurgitation and shown to be closely correlated with regurgitant 
volume for both circular and elliptical orifices17. VC width was preserved as a continuous 
variable, with the exception of descriptive comparisons for which TR by VC width was 
grouped as mild (<4 mm), moderate (4-7 mm), or severe (≥7 mm). The echocardiography 
specialist's (all level III trained) semi-quantitative assessment of TR severity based on color 
Doppler jet appearance and hepatic vein reversal was also abstracted from the clinical 
report. Lastly, TR was assessed by 3-D VC area in a subset of 33 patients during the latter 
part of the study when a routine full volume color Doppler acquisition was added to the 
echocardiographic protocol.
3-D VC area was measured as follows: the 3-D full volume color Doppler dataset was 
opened in the multi-planar reconstruction application, the two orthogonal long-axis planes 
were aligned parallel to the direction of the proximal TR jet, the short axis plane was aligned 
perpendicular to the VC (the narrowest neck of the proximal TR jet just below the flow 
convergence zone), and the resulting short-axis image of the VC was traced to yield VC 
area. As for the measurements of 2-D VC width, the measurements of 3-D VC area were 
repeated and averaged in 2-3 successive beats and in both the apical and parasternal datasets.
Measurement of TLA
The 3-D full volume dataset was imported into the Omni custom software package. The 
open tricuspid leaflets were traced in mid-diastole in multiple planes and reconstructed to 
obtain the TLA, as previously validated on the mitral valve7 (due to overlap of leaflet tissue 
at the coaptation point, tracing in systole is less accurate, and is affected by systolic leaflet 
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stretch). The tricuspid closure area was traced in mid-systole as the leaflet area separating 
the RV and RA necessary to occlude the tricuspid orifice, as required by annular and 
ventricular tethering. The tricuspid annular area (projected onto its least-squares plane) was 
also traced in mid-systole. The ratio of TLA divided by tricuspid closure area was the 
primary predictor variable. A reduction in this ratio represents small valve leaflets relative to 
a larger annulus and more tented closure area, leading to valvular insufficiency. The 
observers underwent training sessions for the Omni software at the study onset and were 
blinded to the TR severity parameters when making leaflet measurements to ensure accuracy 
and prevent bias. Leaflet measurements were made by a second independent observer in a 
random subset of patients to calculate the intraclass coefficients (ICC).
Statistical Methods
Continuous variables were presented as medians with their 25th percentile (Q1) and 75th 
percentile (Q3). Nonparametric Wilcoxon rank-sum tests and Spearman correlations were 
used for univariate analyses. Linear regression was used for multivariable analysis, testing 
the primary hypothesis that the ratio of TLA-to-closure area would be inversely related to 
the TR VC (log transformed due to skewed distribution) after adjusting for covariates. A 
receiver operating characteristics (ROC) curve was also constructed to identify the optimal 
cutoff for the ratio of TLA-to-closure area to predict severe TR. No previous studies on TLA 
were available to guide sample size calculation; however, our previous studies on mitral 
leaflet adaptation were adequately powered with samples sizes of 80-90 patients7,18 such 
that the projected recruitment of 250 patients over a 1-year span was expected to be 
sufficient to test this hypothesis. All analyses were performed with the STATA 13 statistical 
software package (College Station, TX).
Results
The cohort consisted of 164 males and 91 females with a median age of 43.0 years (Q1 36.0, 
Q3 53.0). The median PASP was 79.0 mm Hg (Q1 65.8, Q3 94.6) and the etiology of PH 
was evenly distributed between pre-capillary (N=134, 52.5%) and post-capillary causes 
(N=121, 47.5%). Baseline characteristics stratified by severe vs. non-severe TR are shown 
in Table 1.
TR severity classified according to the VC width was: mild in 116 (45.5%), moderate in 86 
(33.7%), and severe in 53 (20.8%). The distribution was internally consistent with the 
clinical echocardiographer's report that was: mild in 130 (51.0%), moderate in 76 (29.8%), 
and severe in 49 (19.2%). Echocardiographic parameters stratified by severity of TR are 
shown in Table 2. Patients with severe TR were more likely to have increased right atrial 
volume, increased RV volumes, decreased RV and LV ejection fractions (despite a similar 
proportion of post-capillary PH etiology). The median PASP did not vary according to the 
severity of TR.
Compared with healthy controls, patients with PH had a 112% increase in RV enddiastolic 
volume (median 190.0 mL vs. 89.5 mL, P<0.001), a 62% increase in tricuspid annulus area 
(median 11.2 cm2 vs. 6.9 cm2, P<0.001), and a 49% increase in TLA (median 21.4 cm2 vs. 
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14.4 cm2, P<0.001). Those with PH and severe TR had an incremental increase in RV 
volumes, annulus area, and tenting volume (Figure 1).
Despite the increase in RV volumes and annulus area with worsening TR, there was a slight 
decrease in TLA from 22.5 cm2 in patients with mild TR to 20.6 cm2 in patients with severe 
TR. The ratio of TLA-to-closure area was inversely correlated with the VC width (Figure 2). 
Specifically, the ratio of TLA-to-closure area was 2.09, 1.87, and 1.34 in patients with mild, 
moderate, and severe TR, respectively (Spearman's R -0.66, P<0.0001). The area under the 
ROC curve was 0.93 for the ratio of TLA-to-closure area to predict severe TR, and the 
optimal cutoff for this ratio was <1.78 (OR 68.7, 95% CI 16.2, 292.7) (Figure 3).
To further define the interplay between closure area and TLA, patients were divided into 4 
groups based on the presence of large vs. small (> vs. < median) closure area and TLA 
(Figure 4). Patients with large closure area (>11.7 cm2) and small TLA (<21.4 cm2) had a 
markedly greater likelihood of severe TR: median VC width was 8.5 mm in the large closure 
area-small TLA group (N=48), 4.8 mm in the large closure area-large TLA group (N=83), 
3.3 mm in the small closure area-small TLA group (N=76), and 3.0 mm in the small closure 
area-large TLA group (N=48) (Figure 5).
To determine the independent predictors of TR severity, multivariable linear regression was 
performed with log transformed VC width as the dependent variable and the following 
covariates: TLA, closure area, tenting volume, RV end-diastolic volume, PASP, PH 
etiology, age and sex. As shown in Table 3, the independent predictors of greater TR 
severity were smaller TLA (coefficient -0.028, 95% CI -0.041, -0.014), larger closure area 
(coefficient 0.088, 95% CI 0.055, 0.120), larger tenting volume (coefficient 0.298, 95% CI 
0.207, 0.390), and pre-capillary etiology (coefficient 0.100, 95% CI 0.038, 0.162).
In the subset of patients with available 3-D VC area, there was a strong correlation between 
2-D VC width and 3-D VC area (Spearman R=0.75, P<0.001). Severe TR defined by 2-D 
VC width ≥7 mm was discriminated with a high degree of accuracy by 3-D VC area (c-
statistic 0.97). Adding treating center as a covariate in the multivariable model did not affect 
the results. Inter-rater reliability was shown by ICCs of 0.88 and 0.84 for tricuspid leaflet 
area and closure area, respectively.
Discussion
While previous studies have explored annular and subvalvular geometry as determinants of 
functional TR, this study now shows that TLA plays a significant role in the 
pathophysiology. In this prospective cohort of PH patients, RV pressure overload and 
remodeling was associated with a 49% increase in TLA compared with healthy controls. 
When TLA was inadequate to cover the closure area, a graded increase in TR severity was 
observed. The ratio of TLA-to-closure area, reflecting the balance between leaflet adaptation 
versus annular dilation and tethering geometry, proved to be a strong indicator of functional 
TR severity.
The pathophysiology of functional TR has been an area of active research over the past 30 
years, starting with the finding that annular dilatation was a critical component in its 
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development19. Subsequently, it was found that valvular tethering played a major role in the 
development of functional TR20. The factors leading to valvular tethering were reported in a 
series of studies: RV spherical remodeling21, interventricular septal shift22, left ventricular 
interactions23, and RV papillary muscle displacement24,25. This study has added a novel 
mechanistic component – TLA – to our understanding of the pathophysiology of functional 
TR.
The current finding is consistent with recent work on leaflet adaptation in functional mitral 
regurgitation. Compared with normal controls, patients with dilated cardiomyopathy or 
inferior wall motion abnormality had a 35% increase in mitral leaflet area; however, they 
often had a greater relative increase in closure area, such that functional mitral regurgitation 
developed7. A ratio of mitral leaflet area to closure area <1.7 predicted significant valvular 
incompetence, similar to the ratio of <1.78 found in this series of TR. Patients with dilated 
left ventricles in the context of aortic regurgitation were also found to have a 31% increase 
in mitral leaflet area, albeit a preserved ratio of mitral leaflet area to closure area such that 
significant functional mitral regurgitation was very rare18. Interestingly, the biological 
mechanism for increased leaflet area was shown in a sheep model in which mechanical 
leaflet tethering/stress caused by papillary muscle retraction reactivated embryonic pathways 
for leaflet growth8.
Beyond the mechanistic implications, our findings have clinical significance for repair of 
functional TR (most commonly performed for post-capillary PH etiologies). Despite 
contemporary practice of tricuspid valve repair with ring annuloplasty, the incidence of 
residual moderate-to-severe TR is 15-22% within the first month26,27 and up to 44% in long-
term follow-up28. Since ring annuloplasty only addresses one facet of the problem, annular 
dilation, it is not surprising to observe that other facets such as RV spherical remodeling and 
left-sided dysfunction and their resultant tethering effects are the main predictors of 
recurrent TR. Our findings indicate that inadequate TLA relative to the demand for closure 
area imparted by tethering may be another important predictor of recurrent TR. Surgical RV 
reduction by plication of the lateral free wall significantly has been used to address this issue 
at the subvalvular level in a case-series of 17 patients from Germany29. Tricuspid leaflet 
augmentation by autologous pericardial patch at the time of tricuspid ring annuloplasty has 
been used by multiple groups and achieved recurrent TR rates as low as 2%13,14,30,31. 
Newer patch materials using extracellular matrix scaffolds are also under development for 
this purpose32. Our approach to quantify leaflet area may be applied to identify which 
patients could derive the greatest benefit from a leaflet augmentation procedure.
Limitations and future directions. Total TLA was measured, not differential adaptation of 
individual leaflets. Clinically, however, leaflet augmentation procedures empirically achieve 
good results targeting the anterior leaflet and sometimes the anterior portion of the posterior 
leaflet, so this may not alter practice. The Omni custom software package uniquely provides 
total open TLA independent of systolic stretch; commercial vendors have developed similar 
products to measure closed leaflet parameters (e.g. QLAB MVQ, Philips Medical Systems, 
Andover, MA), and could in principle provide open area as well. TR severity was measured 
at a single point in time; longitudinal progression in TR severity as a function of leaflet 
adaptation would be of interest in future studies. VC width may vary when the orifice shape 
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is elliptical33; to minimize the potential error of using single-plane VC width, biplane VC 
was measured in orthogonal views17, and furthermore, validated against 3-D VC area. 
Lastly, there is significant inherent variability in tricuspid valve anatomy, including but not 
limited to the leaflets and subvalvular apparatus, such that the mechanism of functional TR 
is often multifactorial and difficult to predict.
In conclusion, TLA is an important contributor to the development of functional TR. 
Strengths of this study include a prospective two-center design, measurement of 3-D leaflet 
area using a specialized software tool which has been validated against explanted valves7 
and computed tomography34, and gradation of TR severity according to VC, which has been 
shown to be more accurate and reproducible compared to jet area or visual assessment15,35 
and the most prognostic indicator of TR severity36. By integrating TLA with annulus area 
and tenting volume, a more complete understanding of the pathophysiology of functional TR 
is obtained. Fundamentally, this is represented by a simple ratio of TLA-to-closure area, in 
which closure area reflects both annular area and tenting. Future studies may advance the 
utility of these leaflet parameters by demonstrating their ability to select patients in need of 
patch augmentation or other ancillary procedures at the time of tricuspid valve ring 
annuloplasty, and correlating the observed changes in TLA with the biological pathways 
responsible for leaflet proliferation.
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Figure 1. Tricuspid Leaflet Area, Annulus Area, and Tenting Volume in Three Groups
Compared with healthy controls, PH patients had greater median tricuspid leaflet area 
(TLA), annulus area, and tenting volume. Although TLA was similar in PH patients with 
severe TR and non-severe TR, annulus area was significantly larger in those with severe TR 
such that the ratio of TLA-to-annulus area was insufficient to maintain valvular competency. 
Sensitivity analysis showed that these results were not unduly influenced by outlier values.
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Figure 2. Leaflet Area-to-Closure Area Ratio Is Correlated with Severity of TR
The tricuspid leaflet area (TLA)-to-annulus area ratio was found to be inversely correlated 
with the severity of TR as measured by vena contracta width (R=-0.66, P<0.0001).
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Figure 3. Leaflet Area-to-Closure Area Ratio Discriminates Severe TR (ROC Curve)
Receiver operating characteristic (ROC) analysis showing that the tricuspid leaflet area 
(TLA)-to-annulus area ratio discriminated between PH patients with vs. without severe TR 
(odds ratio 68.7, 95% confidence interval 16.2, 292.7), with an area under the ROC curve of 
0.9206 and an optimal cutoff value of 1.78.
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Figure 4. TR Severity as a Function of Leaflet Area and Closure Area < or > Median
PH patients with large tricuspid leaflet area (TLA) and small closure area had the least TR 
(far left), while those with small TLA and large closure area had the most TR (far right).
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Figure 5. Three-Dimensional Renderings of Open Tricuspid Leaflet Area
Demonstrative renderings of the tricuspid leaflet complex used to calculate tricuspid leaflet 
area (TAL). To generate these 3-D models, the tricuspid leaflets were manually traced in the 
open position on successive rotational long-axis planes and then reconstructed using the 
Omni4D statistical software package.
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Table 1
Clinical Characteristics of PH Patients
Severe TR (n=53) Non-severe TR (n=202) P-value
Age, median (Q1, Q3) 45.0 (34.0, 58.0) 43.0 (37.0, 52.0) 0.84
Female sex 17 (32.1) 74 (36.6) 0.63
Coronary artery disease 6 (11.3) 12 (5.9) 0.22
Diabetes 13 (24.5) 43 (21.3) 0.58
Pulmonary embolism 6 (10.3) 11 (5.5) 0.13
Chronic kidney disease 5 (9.4) 16 (7.9) 0.78
NYHA III-IV 45 (84.9) 149 (73.8) 0.24
PH etiology 0.09
    Pre-capillary 33 (62.3) 101 (50.0)
    Post-capillary 20 (37.7) 101 (50.0)
PH therapy 0.50
    None 7 (13.2) 22 (10.9)
    PDE5 inhibitor 15 (28.3) 51 (25.3)
    Endothelin antagonist 15 (28.3) 79 (39.1)
    Prostacyclin 16 (30.2) 50 (24.8)
Abbreviations: Q1, quartile 1; Q3, quartile 3; TR, tricuspid regurgitation; NYHA, New York Heart Association; PH, pulmonary hypertension; 
PDE5, phosphdiesterase-5. Severe TR defined as average vena contracta width ≥7 mm, non-severe TR defined as <7 mm.
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Table 2
Echocardiography Parameters of PH Patients
Severe TR (n=53) Non-severe TR (n=202) P-value
2-D vena contracta width, mm 9.0 (8.4, 9.8) 3.4 (2.7, 5.2) <0.001
3-D vena contracta area, cm2 0.67 (0.59, 0.85) 0.28 (0.20, 0.41) <0.001
PASP, mm Hg 79.0 (69.0, 94.0) 80.0 (64.8, 94.6) 0.81
RA volume, mL 183.5 (132.5, 220.0) 135.0 (98.0, 187.0) 0.001
RV end-diastolic volume, mL 205.0 (189.0, 256.0) 187.0 (152.0, 218.5) 0.001
RV end-systolic volume, mL 146.0 (123.0, 189.0) 122.0 (89.5, 166.5) <0.001
RV stroke volume, mL 57.5 (50.0, 69.0) 57.0 (435, 72.0) 0.56
RV ejection fraction, % 27.5 (23.0, 34.5) 32.0 (23.0, 41.0) 0.07
LV ejection fraction, % 48.0 (33.0, 64.0) 68.5 (62.0, 74.0) 0.04
Leaflet area, cm 20.6 (18.9, 23.1) 21.8 (18.4, 25.4) 0.17
Closure area, cm 15.6 (13.5, 16.8) 10.9 (9.8, 12.4) <0.001
Annulus area, cm 15.8 (13.2, 16.8) 10.8 (9.4, 12.1) <0.001
Leaflet area-to-closure area ratio 1.34 (1.22, 1.56) 1.98 (1.78, 2.16) <0.001
Leaflet area-to-annular area ratio 1.36 (1.24, 1.60) 2.04 (1.70, 2.36) <0.001
Tenting volume, cm3 3.2 (2.9, 3.4) 1.9 (1.5, 2.3) <0.001
Abbreviations: TR, tricuspid regurgitation; PISA, proximal isovelocity surface area; ERO, effective regurgitant orifice; PASP, pulmonary artery 
systolic pressure; RA, right atrium RV, right ventricle; LV, left ventricle. Severe TR defined as average vena contracta width ≥7 mm, non-severe 
TR defined as <7 mm.
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Table 3
Linear Regression to Predict TR Vena Contracta (Log)
Univariable Analysis Multivariable Analysis
Coefficient 95% CI P-value Coefficient 95% CI P-value
Leaflet area, per cm −0.010 (−0.025, 0.005) 0.18 −0.036 (−0.048, −0.024) <0.001
Closure area, per cm 0.117 (0.097, 0.137) <0.001 0.116 (0.208, 0.389) <0.001
Tenting volume, per cm 0.384 (0.314, 0.453) <0.001 0.298 (−0.001, 0.000) <0.001
RV end-diastolic volume, per mL 0.002 (0.0004, 0.003) 0.01 −0.0003 (−0.001, 0.003) 0.41
PASP, per mm Hg 0.002 (−0.001, 0.005) 0.30 0.0008 (−0.219, −0.049) 0.42
Age, per year −0.001 (−0.006, 0.003) 0.57 −0.003 (0.092, 0.141) 0.14
Female −0.030 (−0.170, 0.111) 0.68 −0.026 (−0.006, 0.001) 0.57
Pre-capillary etiology 0.315 (0.260, 0.370) <0.001 0.134 (−0.116, 0.064) 0.002
Abbreviations: PASP, pulmonary artery systolic pressure; RV, right ventricle.
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